Access Biotechnology (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:New York
Access Biotechnology is an investment arm of Access Industries that focuses on private and public biopharma companies across therapeutic areas, modalities, and development stages – from discovery-stage technology platforms to late-stage clinical programs.
Average round investment:144.98m USD
Average number per year:1.50
Portfolio companies:
Hemab
Draig Therapeutics
Hemab
See the entire list
Hemab
Draig Therapeutics
Hemab
See the entire list
Mostly invests in:
Denmark (2)
Health services (3)
Denmark (2)
Health services (3)
Investments
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain